Agilon Health
AGL

$3.52

9.04%

Market Cap: $1.45B

About: Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.

Employees: 1,117

Healthcare Miscellaneous Health & Allied Services

0

Funds holding %

of 6,728 funds

0

Analysts bullish %

of 4 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

68% more call options, than puts

Call options by funds: $22M | Put options by funds: $13.1M

49% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 51

2% more funds holding

Funds holding: 199 [Q1] → 203 (+4) [Q2]

10% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 42

2% less capital invested

Capital invested by funds: $3.03B [Q1] → $2.98B (-$53M) [Q2]

10.5% less ownership

Funds ownership: 121.32% [Q1] → 110.82% (-10.5%) [Q2]

33% less funds holding in top 10

Funds holding in top 10: 3 [Q1] → 2 (-1) [Q2]

See Fund Rankings

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$4

14%

upside

Avg. target

$7

99%

upside

High target

$9

156%

upside

4 analyst ratings

2 positive

50%

2 neutral

50%

0 negative

0%

Deutsche Bank George Hill 67% 1-year accuracy 4 / 6 met price target	14%upside $4	Hold Maintained	9 Aug 2024
Benchmark Bill Sutherland 61% 1-year accuracy 30 / 49 met price target	156%upside $9	Buy Reiterated	8 Aug 2024
RBC Capital Sean Dodge 56% 1-year accuracy 25 / 45 met price target	127%upside $8	Outperform Reiterated	7 Aug 2024
Evercore ISI Group Elizabeth Anderson 58% 1-year accuracy 14 / 24 met price target	99%upside $7	In-Line Maintained	9 Jul 2024

See Analyst Rankings

Financial journalist opinion

agilon health to Participate at 2024 Wells Fargo Healthcare Conference

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 2024 Wells Fargo Healthcare Conference, including a fireside chat presentation on Wednesday, September 4, at 3:00 PM Eastern Time. A simultaneous webcast for the event can be accessed by visiting the “Events & Presentations” section of agilon's Investor Relations website at https://investors.agilonhe.

agilon health to Participate at 2024 Wells Fargo Healthcare Conference

agilon health: Interesting Business Model, But Volatile And Uncertain

agilon hagilon healthealth shares dropped significantly after disappointing financial results, down 11.9% in two days. The company's revenue surged 38.7% year over year, but its net loss nearly doubled, and guidance for 2024 is mixed. Concerns include declining cash reserves, potential for further dilution, and uncertainty regarding share valuation.

agilon health: Interesting Business Model, But Volatile And Uncertain

AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE: AGL) on behalf of long-term stockholders following a class action complaint that was filed against Agilon on March 19, 2024 with Class Period (1) Agilon common stock purchases traceable to the April 2021 initial public offering of Agilon stock; (2) pursuant, or traceable, or both, to materials issued in connection with the Company's secondary public offering that occurred on or about May 16, 2023; and/or (3) common stock between April 15, 2021 and February 27, 2024. Our investigation concerns whether the board of directors of Agilon have breached their fiduciary duties to the company.

AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Magilon health, inc. (AGL) Q2 2024 Earnings Call Transcript

Magilon health, inc. (NYSE:AGL ) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Leland Thomas - VP, IR Steven Sell - CEO Jeffrey Schwaneke - CFO Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Stephen Baxter - Wells Fargo Ryan Daniels - William Blair Elizabeth Anderson - Evercore ISI Adam Ron - Bank of America.

Magilon health, inc. (AGL) Q2 2024 Earnings Call Transcript

Zacks Investment Research

Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment Research

Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates

Agilon Health (AGL) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.04 per share a year ago.

Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates

agilon health Reports Second Quarter 2024 Results

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the second quarter ended June 30, 2024. "Our second quarter results were in-line with our guidance, and we are maintaining medical margin and Adjusted EBITDA guidance for the full year," said Steve Sell, chief executive officer. "We continue to make progress implementing our performance action plan which should contribute t.

agilon health Reports Second Quarter 2024 Results

agilon health Sets Date to Report Second Quarter 2024 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2024 after the market closes on Tuesday, August 6, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international pa.

agilon health Sets Date to Report Second Quarter 2024 Financial Results

agilon health Appoints Karthik Rao, M.D., as Chief Medical Officer

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that after a comprehensive search Karthik Rao, M.D., who has served as agilon's interim chief medical officer (CMO) since February 2024, has been appointed to the permanent CMO role, effective immediately. He previously served as senior medical director and vice president, network performance, at the company. Prior to joining agi.

agilon health Appoints Karthik Rao, M.D., as Chief Medical Officer

The Portnoy Law Firm Announces Investigation of agilon health, inc. (NYSE: AGL)

Investors can contact the law firm at no cost to learn more about recovering their losses.

The Portnoy Law Firm Announces Investigation of agilon health, inc. (NYSE: AGL)

See News Rankings